Last reviewed · How we verify
Complicated Bacteroides Peritonitis
Approved treatments
- Maxipime · Baxter
Cefepime is a cephalosporin antibacterial drug. - Maxipime · Baxter
Cefepime is a cephalosporin antibacterial drug that inhibits bacterial cell wall synthesis. - Cefepim · University Hospital Tuebingen
- Ciprofloxacine · Poitiers University Hospital
- Invanz · Merck & Co.
Invanz works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Noroxin
- Floxin
- Cipro · Bayer AG
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Complicated Bacteroides Peritonitis patent landscape — cliff calendar, originator estates, attackable patents
- Complicated Bacteroides Peritonitis treatment landscape brief
- Complicated Bacteroides Peritonitis treatment updates RSS
Frequently asked questions about Complicated Bacteroides Peritonitis
What drugs treat Complicated Bacteroides Peritonitis?
Tracked treatments include Maxipime, Cefepim, Ciprofloxacine, Invanz, Noroxin, Floxin, Cipro, Ofloxacine.
What is the treatment for Complicated Bacteroides Peritonitis?
Standard treatment for Complicated Bacteroides Peritonitis includes Maxipime, Cefepim, Ciprofloxacine, Invanz, Noroxin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Complicated Bacteroides Peritonitis patent cliff · Complicated Bacteroides Peritonitis CI report
- Treatment: Maxipime · Baxter
- Treatment: Maxipime · Baxter
- Treatment: Cefepim · University Hospital Tuebingen
- Treatment: Ciprofloxacine · Poitiers University Hospital
- Treatment: Invanz · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing